Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial

Marie-Laure Chaix^{1

2}, Isabelle Charreau³, Claire Pintado⁴, Constance Delaugerre^{1

2}, Nadia Mahjoub¹, Laurent Cotte⁵, Catherine Capitant³, François Raffi⁶, Eric Cua⁷, Gilles Pialoux⁸, Cécile Tremblay⁹, Laurence Meyer^{3

10}, Jean-Michel Molina^{2

4}; ANRS IPERGAY Study Group

Collaborators, Affiliations

Collaborators

ANRS IPERGAY Study Group:
C Pintado, B Loze, C Delaugerre, P Charbonneau, C Gatey, D Ponscarme, P Penot, L Niedbalski, R Veron, J Delgado, E Dalle, S Parlier, I Madelaine, J Fonsart, M Danet, N Mahjoub, N Mezreb, K Moudachirou, S Morel, G Conort, F Lorho, M Meunier, W Rozenbaum, J M Molina, J Chas, C Monfort, J Foucoin, B Boissavy, S Cousseau, S Huon, M Danet, A Djessima, V Berrebi, A Adda, S le Nagat, L Zarka, J Berdougo, G Pialoux, C Chidiac, N Mzoughi, F Clement, A Decouty, C Chapolard, M Godinot, C Adouard-Groslafeige, J Koffi, A Pansu, A Becker, S Pailhes, F Bonnet, F Jeanblanc, C Brochier, X Teruin, S Rouby, L Gilly, L Cotte, C Etienne, F Tolonin, S Breaud, V Péchenot, S Bagge, T Cepitelli, P M Roger, E Rosenthal, E Cua, A Cheret, P Cornavin, S Vandamme, J Lambec, N Dumon, O Leclanche, T Huleux, R Biekre, O Robineau, H Melliez, H Bazus, A Pasquet, C Bernaud, M Besnier, B Bonnet, N Hall, M Cavellec, H Hue, L Larmet, M Colas, R Choquet, F Raffi, C Beauvais, P Arlotto, C Fortin, A Talbot, A Chamberland, A McKenzie, M Blanchette, R Rousseau, K Montheuth, J Otis, D Thompson, M Morin, M Wainberg, C Tremblay, L Meyer, C Capitant, I Charreau, B Guillon, E Netzer, N Leturque, J Binesse, V Foubert, M Saouzanet, F Euphrasie, D Carette, J P Aboulker, B Spire, L Sagaon-Teyssier, M Suzan, L Fressard, B Demoulin, G Cattin, N Lorente, V Doré, L Marchand, S Le Mestre, A Mennecier, E Choucair, N Etien, A Diallo, S Gibowski, M-C Simon, J-F Delfraissy, J M Le Gall, S Morel, V Pechenot, S Bagge, A Djessima Taba, M Danet, K Moudachirou, B Dos Santos, J Lambec, S Rouby, X Teruin, N Dumon, V Coquelin, P Brunet, L Gilly, T Cepitelli, R Porion, D Rojas Castro, B Spire, Jean-Michel Molina, Mark Wainberg, Benoit Trottier, Cécile Tremblay, Jean-Guy Baril, Gilles Pialoux, Laurent Cotte, Antoine Chéret, Armelle Pasquet, Eric Cua, Michel Besnier, Willy Rozenbaum, Christian Chidiac, Constance Delaugerre, Nathalie Bajos, Julie Timsit, Gilles Peytavin, Julien Fonsart, Isabelle Durand-Zaleski, Laurence Meyer, Jean-Pierre Aboulker, Bruno Spire, Marie Suzan-Monti, Gabriel Girard, Daniela Rojas Castro, Marie Préau, Michel Morin, David Thompson, Catherine Capitant, Lucie Marchand, Véronique Doré, Marie-Christine Simon, Isabelle Charreau, Joanne Otis, France Lert, Alpha Diallo, Séverine Gibowski, Cecile Rabian

Affiliations

¹ Virologie, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, France.
² Institut National de la Santé et de la Recherche Médicale (INSERM) Unité, Centre National de la Recherche Scientifique Unité Mixte de Recherche, Institut Universitaire d'Hématologie, Sorbonne Paris Cité, Université Paris Diderot, Hôpital Saint Louis, France.
³ INSERM Service Commun, Villejuif, France.
⁴ Maladies Infectieuses, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, France.
⁵ Maladies Infectieuses, Hôpital de la Croix Rousse, Centre Hospitalier et Universitaire de Lyon, France.
⁶ Department of Infectious Diseases, University Hospital of Nantes and Centre d'Investigation Clinique, INSERM, Nantes.
⁷ Maladies Infectieuses, Hôpital de l'Archet, Centre Hospitalier de Nice, France.
⁸ Maladies Infectieuses, Hôpital Tenon, Assistance Publique Hôpitaux de Paris, France.
⁹ Maladies Infectieuses, Centre Hospitalier de l'Université de Montréal, Canada.
¹⁰ Université Paris-Sud, Université Paris-Saclay, France.

PMID: 30539039
PMCID: PMC6286447
DOI: 10.1093/ofid/ofy295

Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial

Marie-Laure Chaix et al. Open Forum Infect Dis. 2018.

. 2018 Nov 8;5(11):ofy295.

doi: 10.1093/ofid/ofy295. eCollection 2018 Nov.

Authors

Collaborators

ANRS IPERGAY Study Group:
C Pintado, B Loze, C Delaugerre, P Charbonneau, C Gatey, D Ponscarme, P Penot, L Niedbalski, R Veron, J Delgado, E Dalle, S Parlier, I Madelaine, J Fonsart, M Danet, N Mahjoub, N Mezreb, K Moudachirou, S Morel, G Conort, F Lorho, M Meunier, W Rozenbaum, J M Molina, J Chas, C Monfort, J Foucoin, B Boissavy, S Cousseau, S Huon, M Danet, A Djessima, V Berrebi, A Adda, S le Nagat, L Zarka, J Berdougo, G Pialoux, C Chidiac, N Mzoughi, F Clement, A Decouty, C Chapolard, M Godinot, C Adouard-Groslafeige, J Koffi, A Pansu, A Becker, S Pailhes, F Bonnet, F Jeanblanc, C Brochier, X Teruin, S Rouby, L Gilly, L Cotte, C Etienne, F Tolonin, S Breaud, V Péchenot, S Bagge, T Cepitelli, P M Roger, E Rosenthal, E Cua, A Cheret, P Cornavin, S Vandamme, J Lambec, N Dumon, O Leclanche, T Huleux, R Biekre, O Robineau, H Melliez, H Bazus, A Pasquet, C Bernaud, M Besnier, B Bonnet, N Hall, M Cavellec, H Hue, L Larmet, M Colas, R Choquet, F Raffi, C Beauvais, P Arlotto, C Fortin, A Talbot, A Chamberland, A McKenzie, M Blanchette, R Rousseau, K Montheuth, J Otis, D Thompson, M Morin, M Wainberg, C Tremblay, L Meyer, C Capitant, I Charreau, B Guillon, E Netzer, N Leturque, J Binesse, V Foubert, M Saouzanet, F Euphrasie, D Carette, J P Aboulker, B Spire, L Sagaon-Teyssier, M Suzan, L Fressard, B Demoulin, G Cattin, N Lorente, V Doré, L Marchand, S Le Mestre, A Mennecier, E Choucair, N Etien, A Diallo, S Gibowski, M-C Simon, J-F Delfraissy, J M Le Gall, S Morel, V Pechenot, S Bagge, A Djessima Taba, M Danet, K Moudachirou, B Dos Santos, J Lambec, S Rouby, X Teruin, N Dumon, V Coquelin, P Brunet, L Gilly, T Cepitelli, R Porion, D Rojas Castro, B Spire, Jean-Michel Molina, Mark Wainberg, Benoit Trottier, Cécile Tremblay, Jean-Guy Baril, Gilles Pialoux, Laurent Cotte, Antoine Chéret, Armelle Pasquet, Eric Cua, Michel Besnier, Willy Rozenbaum, Christian Chidiac, Constance Delaugerre, Nathalie Bajos, Julie Timsit, Gilles Peytavin, Julien Fonsart, Isabelle Durand-Zaleski, Laurence Meyer, Jean-Pierre Aboulker, Bruno Spire, Marie Suzan-Monti, Gabriel Girard, Daniela Rojas Castro, Marie Préau, Michel Morin, David Thompson, Catherine Capitant, Lucie Marchand, Véronique Doré, Marie-Christine Simon, Isabelle Charreau, Joanne Otis, France Lert, Alpha Diallo, Séverine Gibowski, Cecile Rabian

Affiliations

¹ Virologie, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, France.
² Institut National de la Santé et de la Recherche Médicale (INSERM) Unité, Centre National de la Recherche Scientifique Unité Mixte de Recherche, Institut Universitaire d'Hématologie, Sorbonne Paris Cité, Université Paris Diderot, Hôpital Saint Louis, France.
³ INSERM Service Commun, Villejuif, France.
⁴ Maladies Infectieuses, Hôpital Saint-Louis, Assistance Publique Hôpitaux de Paris, France.
⁵ Maladies Infectieuses, Hôpital de la Croix Rousse, Centre Hospitalier et Universitaire de Lyon, France.
⁶ Department of Infectious Diseases, University Hospital of Nantes and Centre d'Investigation Clinique, INSERM, Nantes.
⁷ Maladies Infectieuses, Hôpital de l'Archet, Centre Hospitalier de Nice, France.
⁸ Maladies Infectieuses, Hôpital Tenon, Assistance Publique Hôpitaux de Paris, France.
⁹ Maladies Infectieuses, Centre Hospitalier de l'Université de Montréal, Canada.
¹⁰ Université Paris-Sud, Université Paris-Saclay, France.

PMID: 30539039
PMCID: PMC6286447
DOI: 10.1093/ofid/ofy295

Abstract

We evaluated the impact of on-demand oral tenofovir disoproxil fumarate (TDF)/emtricitabine (FTC) for pre-exposure prophylaxis (PrEP) on herpes simplex virus (HSV)-1/2 incidence among men who have sex with men (MSM) enrolled in the ANRS IPERGAY trial. Serum samples were tested at baseline and at the last visit for HSV-1/2 antibodies. Overall HSV-1 incidence was 11.7 per 100 person-years; 16.2 and 7.8 per 100 person-years in the TDF/FTC and placebo arm, respectively (P = .19). Overall HSV-2 incidence was 7.6 per 100 person-years; 8.1 and 7.0 per 100 person-years in the TDF/FTC and placebo arm, respectively (P = .75). On-demand oral PrEP with TDF/FTC failed to reduce HSV-1/2 incidence in this population.

Keywords: HSV1/2 incidence; HSV1/2 prevalence; MSM; PrEP; TDF/FTC.

PubMed Disclaimer

References

1. Looker KJ, Magaret AS, May MT, et al. . Global and regional estimates of prevalent and incident herpes simplex virus type 1 infections in 2012. PLoS ONE 2015; 10:e0140765. - PMC - PubMed
1. Looker KJ, Elmes JAR, Gottlieb SL, et al. . Effect of HSV-2 infection on subsequent HIV acquisition: an updated systematic review and meta-analysis. Lancet Infect Dis 2017; 17:1303–16. - PMC - PubMed
1. Abdool Karim Q, Abdool Karim SS, Frohlich JA, et al. . Effectiveness and safety of tenofovir gel, an antiretroviral microbicide, for the prevention of HIV infection in women. Science 2010; 329:1168–74. - PMC - PubMed
1. Andrei G, Lisco A, Vanpouille C, et al. . Topical tenofovir, a microbicide effective against HIV, inhibits herpes simplex virus-2 replication. Cell Host Microbe 2011; 10:379–89. - PMC - PubMed
1. Abdool Karim SS, Abdool Karim Q, Kharsany AB, et al. . Tenofovir gel for the prevention of herpes simplex virus type 2 infection. N Engl J Med 2015; 373:530–9. - PMC - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial

Collaborators

Affiliations

Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial

Authors

Collaborators

Affiliations

Abstract

References

LinkOut - more resources

Full Text Sources

Medical

Miscellaneous